• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

膀胱侵犯局限性前列腺癌行膀胱前列腺切除术治疗后患者的生活质量。

Quality of life among patients after cystoprostatectomy as the treatment for locally advanced prostate cancer with bladder invasion.

机构信息

Department of Urology, Tongji Hospital, Tongji Medical School, Huazhong University of Science and Technology, Wuhan, China.

出版信息

Aging Male. 2020 Dec;23(5):847-853. doi: 10.1080/13685538.2019.1604653. Epub 2019 Apr 23.

DOI:10.1080/13685538.2019.1604653
PMID:31012363
Abstract

PURPOSE

This study aimed to evaluate the changes of patients' quality of life (QoL) after cystoprostatectomy as a treatment for locally advanced prostate cancer (LAPC) with the bladder invasion and to determine risk factors for postoperative poor QoL.

MATERIALS AND METHODS

Between Jan 2012 and December 2015, 27 patients who received cystoprostatectomy for LAPC with the bladder invasion were retrospectively included. QoL was assessed with the functional assessment of cancer therapy-prostate (FACT-P) questionnaire scores. Determinants for postoperative poor QoL were investigated using univariate and multivariate regression analysis.

RESULTS

Three-year overall survival, biochemical progression-free survival, and clinical progress-free survival were 88.89%, 62.96% and 77.78%, respectively. Preoperative symptoms of hematuria, urinary frequency, and dysuria were well alleviated after cystoprostatectomy. Moreover, FACT-P questionnaire scores at 6 months and 1 year after cystoprostatectomy were significantly higher than preoperative scores. Univariate and multivariable analysis ( < .05) showed that postoperative complication was the independent risk factor for the loss of postoperative QoL.

CONCLUSIONS

Patients' QoL can be improved after cystoprostatectomy as the treatment for LAPC with the bladder invasion, which is associated with ameliorative urinary symptoms after the surgery. Besides, surgical complication is identified to be a risk factor for postoperative poor QoL.

摘要

目的

本研究旨在评估膀胱癌侵犯局部晚期前列腺癌(LAPC)患者行膀胱全切术后生活质量(QoL)的变化,并确定术后 QoL 较差的危险因素。

材料和方法

回顾性纳入 2012 年 1 月至 2015 年 12 月间因膀胱癌侵犯接受膀胱全切术治疗的 27 例 LAPC 患者。采用癌症治疗功能评估-前列腺量表(FACT-P)问卷评分评估 QoL。采用单因素和多因素回归分析探讨术后 QoL 较差的决定因素。

结果

患者 3 年总生存率、生化无进展生存率和临床无进展生存率分别为 88.89%、62.96%和 77.78%。膀胱全切术后,患者术前血尿、尿频和尿痛等症状均得到明显缓解。此外,膀胱全切术后 6 个月和 1 年的 FACT-P 问卷评分均明显高于术前评分。单因素和多因素分析(<0.05)表明术后并发症是术后 QoL 丧失的独立危险因素。

结论

膀胱癌侵犯局部晚期前列腺癌患者行膀胱全切术治疗后 QoL 可得到改善,这与术后尿路症状改善有关。此外,手术并发症被确定为术后 QoL 较差的危险因素。

相似文献

1
Quality of life among patients after cystoprostatectomy as the treatment for locally advanced prostate cancer with bladder invasion.膀胱侵犯局限性前列腺癌行膀胱前列腺切除术治疗后患者的生活质量。
Aging Male. 2020 Dec;23(5):847-853. doi: 10.1080/13685538.2019.1604653. Epub 2019 Apr 23.
2
The role of cystoprostatectomy in management of locally advanced prostate cancer: a systematic review.根治性膀胱前列腺切除术在局部进展性前列腺癌治疗中的作用:系统评价。
World J Surg Oncol. 2020 Jan 20;18(1):14. doi: 10.1186/s12957-020-1791-5.
3
Total cystoprostatectomy in the treatment of locally advanced prostate carcinoma.全膀胱前列腺切除术治疗局部晚期前列腺癌。
Aktuelle Urol. 2003 Jul;34(4):259-61. doi: 10.1055/s-2003-41611.
4
Evaluation of cystoprostatectomy on patients with prostate cancer extending to bladder: a retrospective study from single center.评价膀胱前列腺切除术治疗前列腺癌侵犯膀胱患者的效果:单中心回顾性研究。
BMC Urol. 2022 Jul 28;22(1):118. doi: 10.1186/s12894-022-01068-7.
5
Incidental prostate cancer in Asian men: high prevalence of incidental prostatic adenocarcinoma in Chinese patients undergoing radical cystoprostatectomy for treatment of bladder cancer and selection of candidates for prostate-sparing cystectomy.亚洲男性中的偶发性前列腺癌:接受根治性膀胱前列腺切除术治疗膀胱癌的中国患者中偶发性前列腺腺癌的高患病率及保留前列腺的膀胱切除术候选者的选择。
Prostate. 2015 Jun;75(8):845-54. doi: 10.1002/pros.22966. Epub 2015 Feb 19.
6
What is the correct staging and treatment strategy for locally advanced prostate cancer extending to the bladder?侵犯膀胱的局部晚期前列腺癌的正确分期及治疗策略是什么?
Arch Ital Urol Androl. 2015 Jul 7;87(2):130-5. doi: 10.4081/aiua.2015.2.130.
7
[Value of cystoprostatectomy in locally advanced prostate carcinoma].[膀胱前列腺切除术在局部晚期前列腺癌中的价值]
Urologe A. 2008 Nov;47(11):1447-52. doi: 10.1007/s00120-008-1725-2.
8
Characterization and risk stratification of prostate cancer in patients undergoing radical cystoprostatectomy.根治性膀胱前列腺切除术患者的前列腺癌特征和风险分层。
Int J Urol. 2013 Sep;20(9):866-71. doi: 10.1111/iju.12073. Epub 2013 Feb 4.
9
Synchronous bladder and prostate cancers in the specimens of radical cystoprostatectomy: a multicenter retrospective analysis.根治性膀胱前列腺切除术标本中的同步性膀胱癌和前列腺癌:一项多中心回顾性分析
Kaohsiung J Med Sci. 2014 Jul;30(7):371-5. doi: 10.1016/j.kjms.2014.02.011. Epub 2014 Apr 2.
10
[A Case of Robot-Assisted Radical Cystoprostatectomy for Locally Advanced Prostate Cancer with Bladder Infiltration].[机器人辅助根治性膀胱前列腺切除术治疗局部进展期前列腺癌伴膀胱浸润1例]
Hinyokika Kiyo. 2021 Apr;67(4):163-166. doi: 10.14989/ActaUrolJap_67_4_163.

引用本文的文献

1
Long-term oncological outcomes after multimodal treatment for locally advanced prostate cancer.局部晚期前列腺癌多模式治疗后的长期肿瘤学结局
BJUI Compass. 2024 Aug 1;5(9):885-892. doi: 10.1002/bco2.414. eCollection 2024 Sep.
2
Multimodal therapy including robot-assisted radical cystoprostatectomy for locally advanced prostate cancer with bladder and ureteral invasion: A case report.多模式治疗,包括机器人辅助根治性膀胱前列腺切除术治疗局部晚期前列腺癌伴膀胱和输尿管侵犯:一例报告。
IJU Case Rep. 2022 Jun 29;5(5):402-405. doi: 10.1002/iju5.12500. eCollection 2022 Sep.
3
The auxiliary diagnostic value of prostate-specific antigen and α-methylacyl-CoA racemase in prostate cancer.
前列腺特异性抗原和α-甲基酰基辅酶A消旋酶在前列腺癌中的辅助诊断价值。
Oncol Lett. 2020 Aug;20(2):1418-1422. doi: 10.3892/ol.2020.11658. Epub 2020 May 21.